Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 2, 2011, Pages 510-522

  Vignisse, Julie ^a,b   Steinbusch, Harry W M ^a   Bolkunov, Alexei ^c   Nunes, Joao ^a,d   Santos, Ana Isabel ^e   Grandfils, Christian ^b   Bachurin, Sergei ^c   Strekalova, Tatyana ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

^d UNIVERSITY OF LISBON   (Portugal)

^e UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Alzheimer's disease; Dimebon; Hippocampus dependent memory; Mouse

Indexed keywords

DIMEBON;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG MECHANISM; EXPLORATORY BEHAVIOR; FLUID INTAKE; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LOCOMOTION; MALE; MAZE TEST; MEMORY; MOUSE; NONHUMAN; REWARD; SCORING SYSTEM; TASK PERFORMANCE; WATER DEPRIVATION;

ANIMALS; ANXIETY; APPETITIVE BEHAVIOR; AVOIDANCE LEARNING; DRINKING; EXPLORATORY BEHAVIOR; HIPPOCAMPUS; INDOLES; LEARNING; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED C57BL; NOOTROPIC AGENTS; TIME FACTORS;

EID: 79952901355     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.007     Document Type: Article

References (74)

1. Albasser M.M., Chapman R.J., Amin E., Iordanova M.D., Vann S.D., Aggleton J.P. New behavioral protocols to extend our knowledge of rodent object recognition memory. Learn Mem 2010, 17:407-419.
2. Alhassan A.W., Bauchi Z.M., Adebisi S.S., Mabrouk M.A., Sabo A.M. The effect of early administration of glucocorticoids on learning and spatial memory. Niger J Physiol Sci 2009, 24:137-139.
3. Bachurin S., Bukatina E., Lermontova N., Tkachenko S., Afanasiev A., Grigoriev V., et al. Antihistamine agent dimebon as a novel neuroprotector and a cognition enhancer. Ann NY Acad Sci 2001, 939:425-435.
4. Bachurin S., Shevtsova E., Kireeva E., Oxenkrug G., Sablin S. Mitochondria as a target for neurotoxins and neuroprotective agents. Ann NY Acad Sci 2003, 993:334-344.
5. Bachurin S., Serkova T., Lermontova N., Ivanova T., Beznosko B., Vankin G., et al. Comparative study of aricept, memantine and dimebon effect on memory and cognition in neurotoxin-induced animal model of Alzheimer's disease. Abstracts of 10th International Conference on Alzheimer's Disease and Related Disorder, July 15-20, Chicago 2006.
6. Bachurin S.O, Grigoriev V.V. A drug demonstrating anxiolytic effect based on hydrogenated pyrido (4,3-B) indoles, its pharmacological compound and application method WO2009005771 (A1).
7. Balschun D., Zuschratter W., Wetzel W. Allosteric enhancement of metabotropic glutamate receptor 5 function promotes spatial memory. Neuroscience 2006, 142:691-702.
8. Benchenane K., Peyrache A., Khamassi M., Tierney P.L., Gioanni Y., Battaglia F.P., et al. Coherent theta oscillations and reorganization of spike timing in the hippocampal- prefrontal network upon learning. Neuron 2010, 66:921-936.
9. Bernales S., Alarcon R., Guerrero J., Higaki J.N., Protter A.A. Dimebon induces neurite outgrowth from hippocampal, spinal, and cortical neurons. Neurology 2009, 72:A:385.
10. Bolkunov A, Beznosko B, Bachurin S. Effects of dimebon in the new object recognition test in mice. (in preparation).
11. Cammarota M., Bevilaqua L.R.M., Rossato J.I., Ramirez M., Medina J.H., Izquierdo I. Relationship between short- and long-term memory and short- and long-term extinction. Neurobiol Learn Mem 2005, 84:25-32.
12. Cavalli A., Bolognesi M.L., Minarini A., Rosini M., Tumiatti V., Recanatini M., et al. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 2008, 5:347-372.
13. Chuhan Y.S., Taukulis H.K. Impairment of single-trial memory formation by oral methylphenidate in the rat. Neurobiol Learn Mem 2006, 85:125-131.
14. Combarros O, Rodríguez-Rodríguez E, Mateo I, Vázquez-Higuera JL, Infante J, Berciano J, Sánchez-Juan P. Neurobiol Aging 2009 [Epub ahead of print].
15. Da Silva Costa V., Duchatelle P., Boulouard M., Dauphin F. Selective 5-HT6 receptor blockade improves spatial recognition memory and reverses age-related deficits in spatial recognition memory in the mouse. Neuropsychopharm 2009, 34:488-500.
16. Dolgov O., Gorenkova N., Bartsch D., Strekalova T. Distinct behavioral and cognitive correlates of hedonic deficit in a new model of stress-induced anhedonia in mice. Proceedings of the 6th Meeting of the German Neuroscience Society 2005, http://www.neuro.uni-goettingen.de.
17. Doody R.S., Gavrilova S.I., Sano M., Thomas R.G., Aisen P.S., Bachurin S.O., et al. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008, 372:207-215.
18. Dulawa S.C., Hen R. Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neurosci Biobehav Rev 2005, 29:771-783.
19. Epp J.R., Spritzer M.D., Galea L.A. Hippocampus-dependent learning promotes survival of new neurons in the dentate gyrus at a specific time during cell maturation. Neurosci 2007, 149:273-285.
20. Finger B.C., Dinan T.G., Cryan J.F. Leptin-deficient mice retain normal appetitive spatial learning yet exhibit marked increases in anxiety-related behaviours. Psychopharmacol Berl 2010, 210:559-568.
21. Foerstl H. Neuro-enhancement. Brain doping. Nervenarzt 2009, 80:840-846.
22. Galani R., Weiss I., Cassel J.C., Kelche C. Spatial memory, habituation, and reactions to spatial and nonspatial changes in rats with selective lesions of the hippocampus, the entorhinal cortex or the subiculum. Behav Brain Res 1998, 96:1-12.
23. Gerlai R. Behavioral tests of hippocampal function: simple paradigms complex problems. Behav Brain Res 2001, 125:269-277.
24. Giorgetti M., Gibbons J.A., Bernales S., Alfaro I.E., La Rochelle C.D., Cremers T., et al. Cognition enhancing properties of dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or NMDA receptor antagonism. J Pharmacol Exp Ther 2010, 333:748-757.
25. Gold P.E. The many faces of amnesia. Learn Mem 2006, 13:506-514.
26. Gorenkova N., Kunert J., Berger S., Strekalova T., Bartsch D. Gene expression profiling in sterssed mice with and without depressive-like syndrome. Proceedings of EMBO conference of Young Investigator Awardees 2005, http://www. embo.Org/about_embo/EMBO_AR_2005.pdf.
27. Grigorev V.V., Dranyi O.A., Bachurin S.O. Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med 2003, 136:474-477.
28. Grigoriev V.V. A Development of the System of Identification of Correction of Cognitive Impairments during Neurodegenerative Disorders among Glutamate Receptor Ligands 2009, Max Press, Moscow, 1-49.
29. Gura T. Hope in Alzheimer's fight emerges from unexpected places. Nat Med 2008, 14:894.
30. Haller J., Halász J., Makara G.B. Housing conditions and the anxiolytic efficacy of buspirone: the relationship between main and side effects. Behav Pharmacol 2000, 5:403-412.
31. Hung D. Dimebon: A phase 3 investigational agent for Alzheimer's disease with a novel mitochondrial mechanism of action. Alzheimers Dement 2008, 4:182-183.
32. Iliyuchenok T.I., Matveeva I.A. Dimebon - a novel antihistaminergic agent. New Pharm agents 1989, 4:12-16. [Article in Russian].
33. Izquierdo I., Bevilaqua L.R.M., Rossato J.I., Bonini J.S., Medina J.H., Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends Neurosci 2006, 29:496-505.
34. Izquierdo Y., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structure. Neurobiol Learn Mem 1997, 68:285-316.
35. Kieburtz K., McDermott M.P., Voss T.S., Corey-Bloom J., Deuel L.M., Dorsey E.R., et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Arch Neurol 2010, 67:154-160.
36. LaLumiere R.T., Buen T.V., McGaugh J.L. Post-training intra-basolateral amygdala infusions of norepinephrine enhance consolidation of memory for contextual fear conditioning. J Neurosci 2003, 23:6754-6758.
37. Lermontova N.N., Lukoyanov N.V., Serkova T.P., Lukoyanova E.A., Bachurin S.O. Dimebon improves learning in animals with experimental Alzheimer's disease. Bull Exp Biol Med 2000, 129:544-546.
38. Lermontova N.N., Redkozubov A.E., Shevtsova E.F., Serkova T.P., Kireeva E.G., Bachurin S.O. Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels. Bull Exp Biol Med 2001, 132:1079-1083.
39. Lermontova N.N., Mukhina T.V., Vankin G.I., Serkova T.P., Bachurin S.O. Comparison of the Effect of NT-0409 and antidementia drugs on learning and memory in rats with chronic cerebral cholinergic dficiency. Bull Exp Biol Med 2003, 135:58-61.
40. Li B., Wanka L., Blanchard J., Liu F., Chohan M.O., Iqbal K., et al. Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice. FEBS Lett 2010, 584:3359-3365.
41. Liu P., Jarrard L.E., Bilkey D.K. Excitotoxic lesions of the pre- and parasubiculum disrupt object recognition and spatial memory processes. Behav Neurosci 2001, 115:112-124.
42. Loiseau F., Le Bihan C., Hamon M., Thiébot M.H. Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats. Behav Pharmacol 2003, 14:447-455.
43. Lorenzini C.A., Baldi E., Bucherelli C., Sacchetti B., Tassoni G. Role of hippocampus acquisition, consolidation and retrieval of rat's passive avoidance response: a tetrodoxin functional inactivation study. Brain Res 1996, 730:32-39.
44. Lynch G., Gall C.M. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci 2006, 10:554-562.
45. Merali Z., Levac C., Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 2003, 54:552-565.
46. Miller G. The puzzling rise and fall of a dark-horse Alzheimer's drug. Science 2010, 327(5971):1309.
47. O'Brien J.T. A promising new treatment for Alzheimer's disease?. Lancet Neurol 2008, 7:768-769.
48. Okun I., Tkachenko S.E., Khvat A., Mitkin O., Kazey V., Ivachtchenko A.V. From anti-allergic to anti-Alzheimer's: molecular pharmacology of dimebon. Curr Alzheimer Res 2010, 7:97-112.
49. Orsetti M., Ghi P., Di Carlo G. Histamine H(3)-receptor antagonism improves memory retention and reverses the cognitive deficit induced by scopolamine in a two-trial place recognition task. Behav Brain Res 2001, 124:235-242.
50. Passani M.B., Giannoni P., Bucherelli C., Baldi E., Blandina P. Histamine in the brain: beyond sleep and memory. Biochem Pharmacol 2007, 73:1113-1122.
51. Perlovich G.L., Volkova T.V., Kurkov S.V., Proshin A.N., Petrova L.N., Bachurin S.O. Novel salts of dibenzylamine derivative isothiourea as potent neuroprotectors and cognition-enhancers: synthesis, biological and physicochemical properties. J Med Chem 2009, 52:1845-1852.
52. Pieper A.A., Xie S., Capota E., Estill S.J., Zhong J., Long J.M., et al. Discovery of a proneurogenic, neuroprotective chemical. Cell 2010, 142:39-51.
53. Protter A., Vartiainen V., Yrjanheikki J., Bernales S. Neurite outgrowth and mitochondrial function in dimebon treated rat cortical cultures. Neurodegener Dis 2009, 6. Abstract 1536.
54. Reddy P.V., Devi K. Intrastrain variations in anxiolytic effect of nitrazepam in mice. Indian J Physiol Pharmacol 2006, 50:309-312.
55. Rogawski M.A., Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev 2003, l;3:275-308.
56. Schaffhauser H., Mathiasen J.R., Dicamillo A., Huffman M.J., Lu L.D., McKenna B.A., et al. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 2009, 78:1035-1042.
57. Smith J.W., Al-Khamees O., Costall B., Naylor R.J., Smythe J.W. Chronic aspirin ingestion improves spatial learning in adult and aged rats. Pharmacol Biochem Behav 2002, 71:233-238.
58. Steele J.W., Kim S.H., Cirrito J.R., Verges D.K., Restivo J.L., Westaway D., et al. Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Mol Neurodegener 2009, 17:51.
59. Strekalova T., Sun M., Sibbe M., Evers M., Dityatev A., Gass P., et al. Fibronectin domains of extracellular matrix molecule tenascin-C modulate hippocampal learning and synaptic plasticity. Mol Cell Neurosci 2002, 21:173-187.
60. Strekalova T., Wotjak C., Schachner M. Intrahippocampal administration of an antibody against the HNK-1 carbohydrate impairs memory consolidation in an inhibitory learning task in mice. Mol Cell Neurosci 2001, 17:1102-1113.
61. Strekalova T., Spanagel R., Bartsch D., Henn F., Gass P. Stressed-induced anhedonia in mice is associated with deficits in forced swimming and exploration. Neuropsychopharm 2004, 11:2007-2017.
62. Strekalova T., Spanagel R., Dolgov O., Bartsch D. Stress-induced hyperlocomotion as a confounding factor in anxiety and depression models in mice. Behav Pharm 2005, 16:171-180.
63. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D. Selective effects of citalopram in the mouse model of stress-induced anhedonia with control effects for chronic stress. Behav Pharm 2006, 17:271-287.
64. Strekalova T., Steinbusch H. Factors of reproducibility of stress-induced anhedonia in chronic stress depression models in mice. Mood and Anxiety Related Phenotypes in Mice: Characterization using Behavioral Tests 2009, 153-176. Humana Press, Totowa, NJ. T. Gould (Ed.).
65. Strekalova T., Steinbusch H.W.M. Measuring behavior in mice with chronic stress depression paradigm. Progr Neuro Psychopharm Biol Psych 2010, 34:348-361.
66. Tan W.F., Cao X.Z., Wang J.K., Lv H.W., Wu B.Y., Ma H. Protective effects of lithium treatment against spatial memory deficits induced by tau hyperphosphorylation in splenectomized rats. Clin Exp Pharmacol Physiol 2010, 37:1010-1015.
67. Takase L.F., Fornal C.A., Jacobs B.L. Effects of the hypnotic drug zolpidem on cell proliferation and survival in the dentate gyrus of young and old rats. Brain Res 2009, 1259:26-31.
68. Tokarski K, Draguhn A, Gorenkova N, Schunk E, Kunchulia, Dolgov O, Steinbusch H, Strekalova T. Hippocampal plasticity in mice with and without hedonic deficit after stress and pre-treatment by citalopram. PLoSOne (under revision).
69. Ungerer A., Mathis C., Mélan C. Are glutamate receptors specifically implicated in some forms of memory processes?. Exp Brain Res 1998, 123:45-51.
70. Van Ruitenbeek P., Vermeeren A., Riedel W.J. Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased. Eur Neuropsychopharmacol 2010, 4:226-235.
71. Wong E.H., Nikam S.S., Shahid M. Multi- and single-target agents for major psychiatric diseases: therapeutic opportunities and challenges. Curr Opin Investig Drugs 2008, 9:28-36.
72. Wu J., Li Q., Bezprozvanny I. Evaluation of dimebon in cellular model of Huntington's disease. Mol Neurodegener 2008, 3:15.
73. Yang W.M., Shim K.J., Choi M.J., Park S.Y., Choi B.J., Chang M.S., et al. Novel effects of Nelumbo nucifera rhizome extract on memory and neurogenesis in the dentate gyrus of the rat hippocampus. Neurosci Lett 2008, 443:104-107.
74. Youdim M.B., Buccafusco J.J. Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci 2005, 26:27-35.